close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar931505Point86
Implied share price

Buy Undervalued by 1221547.0%

5% margin of safety What's this?

EV / EBITDA
Use Average
GENZ
Genzyme Corporation
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
AMGN
Amgen, Inc.
Change
295142.9 23.69 392789.88 33.63 5.56 18.01
All amounts in millions
from last financial year
         
Implied Share Price $931505.86 $46941.29 $952470.16 $2743998.72 $2891000.11
Market Cap 18,291 1,229,412 159,224 126,048 121,501
Net Debt -371 20 4,504 6,333 12,727
Enterprise Value (EV) 18,961 1,229,432 163,728 68,248 134,228
Revenue 4,048 44 11,201 33,306 18,676
EBITDA 800 3 4,868 12,279 7,451
Percent 19.8 % 7.1 % 43.5 % 36.9 % 39.9 %
EBIT 332 1 4,524 6,793 6,165
Percent 8.2 % 3.6 % 40.4 % 20.4 % 33.0 %
Balance Sheet          
Total Assets 10,913 58 22,496 96,055 66,125
Total Liabilities 3,326 56 11,127 39,151 44,029
Shareholders Equity 7,586 2 11,369 56,904 22,096.0

Comments

No comments yet. Login to comment.